Skip to main content

EnClear Therapies

Cambridge, United States

EnClear Therapies is a biotechnology company developing device-based therapies for the treatment of neurodegenerative disease

$5.0M raised
Sep 2024
Grant

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about EnClear Therapies

How much funding has EnClear Therapies raised?
EnClear Therapies has raised $5.0M in total funding. The most recent round was Grant. The last funding was announced in September 2024.
Who are EnClear Therapies's investors?
EnClear Therapies's investors include Founders Fund, Presight Capital, Tachyon Ventures, Thiel Capital, Amgen Ventures.
Where is EnClear Therapies headquartered?
EnClear Therapies is headquartered in Cambridge, United States.
What does EnClear Therapies do?
EnClear Therapies is a biotechnology company developing device-based therapies for the treatment of neurodegenerative disease
What stage is EnClear Therapies at?
EnClear Therapies is at the Grant stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"EnClear Therapies — Funding & Investors." VCBacked, September 3, 2024, https://www.vcbacked.co/company/enclear-therapies. Accessed July 1, 2026.
APA
VCBacked. (2024). EnClear Therapies — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/enclear-therapies
Wikipedia (cite web)
{{cite web |title=EnClear Therapies — Funding & Investors |url=https://www.vcbacked.co/company/enclear-therapies |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .